Expand VNDA Menu
VNDA MENU

VNDA Stock Posts


VNDA #VandaPharmaceuticals stock increases 5.3% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals5.45-0.40-6.8%

After Hours:5.74+0.29 (+5.3%)

Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe

PRNewswireThu, 16-Jul 4:30 PM
Upcoming Earnings

VNDA Vanda Pharmaceuticals7.52+0.13 (+1.8%)

Vanda Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±9.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±12.6%. View Expected Move (Conf Call: May 6 4:30 PM)
VNDA #VandaPharmaceuticals stock increases 4.0% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals7.00-0.10-1.4%

After Hours:7.28+0.28 (+4.0%)

Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years

PRNewswireFri, 1-May 4:36 PM
VNDA #VandaPharmaceuticals stock increases 5.1% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals7.00-0.10-1.4%

After Hours:7.36+0.36 (+5.1%)

Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years

PRNewswireFri, 1-May 4:36 PM
Unusual Option Volume

VNDA Vanda Pharmaceuticals8.29-0.28 (-3.3%)

Vanda Pharmaceuticals trades 2,646 contracts. The company has the following event: on Dec 12, 2026. News: Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods
View Details...
Unusual Option Volume

VNDA Vanda Pharmaceuticals9.28-0.01 (-0.1%)

Vanda Pharmaceuticals trades 3,468 contracts. The company has the following event: on Dec 12, 2026.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes